Early is good

Early is Good is a provider of cancer research and molecular biomarkers services. Their non-subjective BC diagnostic tests can identify substances indicative of cancer in the body with greater accuracy and specificity than a cystoscopy, allowing for earlier and more widely accessible detection of diseases. Their biomarker-based approach helps patients receive early and accurate diagnoses, improving outcomes and quality of life.